NCT07842458 Depth Electrode Cortical Reverberation Monitoring After Traumatic Brain Injury
| NCT ID | NCT07842458 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Samuel Cramer |
| Condition | Traumatic Brain Injury |
| Study Type | INTERVENTIONAL |
| Enrollment | 15 participants |
| Start Date | 2026-05-01 |
| Primary Completion | 2027-01-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 15 participants in total. It began in 2026-05-01 with a primary completion date of 2027-01-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a preliminary, prospective interventional feasibility study to investigate the use of cortical reverberation (CR) monitoring in patients with traumatic brain injury (TBI) requiring a clinically indicated external ventricular drain (EVD) placement.
Eligibility Criteria
Inclusion Criteria: 1. 18 years or older 2. Consenting party must be able to provide written consent in English 3. Patient recommended to undergo EVD placement for the monitoring and possible treatment of ICP after TBI Exclusion Criteria: 1. Contaminated scalp lacerations 2. Known systemic infection 3. Non-English speaking 4. Fixed, uncorrectable coagulopathy 5. Pregnant, minors, or wards of the state
Frequently Asked Questions
Who can join the NCT07842458 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Traumatic Brain Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07842458 currently recruiting?
Yes, NCT07842458 is actively recruiting participants. Visit ClinicalTrials.gov or contact Samuel Cramer to inquire about joining.
Where is the NCT07842458 trial being conducted?
This trial is being conducted at Minneapolis, United States.
Who is sponsoring the NCT07842458 clinical trial?
NCT07842458 is sponsored by Samuel Cramer. The trial plans to enroll 15 participants.